Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis
NCT02456935
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
280
Enrollment
INDUSTRY
Sponsor class
Conditions
Erosive Esophagitis
Interventions
DRUG:
CJ-12420 100 mg QD
DRUG:
Esomeprazole 40 mg QD
Sponsor
HK inno.N Corporation